Intuitive Surgical is a pioneering medical device company specializing in robotic-assisted surgical systems, most notably the da Vinci Surgical System. This innovative platform enhances the precision and control of minimally invasive surgical procedures, enabling surgeons to perform operations with greater accuracy and reduced recovery times for patients. The company is dedicated to advancing the field of robotics in surgery, providing training and support for healthcare professionals, and continually innovating its technology to improve patient outcomes across various medical specialties. Read More
What Happened? Shares of medical technology company Intuitive Surgical (NASDAQ:ISRG) jumped 7.6% in the afternoon session after the company reported strong f...
Medical technology company Intuitive Surgical (NASDAQ:ISRG) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 23% year on year...
Medical technology company Intuitive Surgical (NASDAQ:ISRG) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 23% year on...
SUNNYVALE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2026.
Medical technology company Intuitive Surgical (NASDAQ:ISRG) will be reporting earnings this Tuesday afternoon. Here’s what to expect. Intuitive Surgical beat...
Johnson & Johnson (NYSE: JNJ) delivered a robust first-quarter 2026 earnings report on April 14, 2026, handily beating Wall Street expectations and signaling a successful navigation of the long-feared "Stelara" patent cliff. The healthcare titan reported an adjusted earnings per share (EPS) of $2.70, comfortably ahead of the $2.66
